CAXTON CORP 13D and 13G filings for CTI BioPharma Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:01 pm Sale | 2021-12-31 | 13G | CTI BioPharma Corp. CTIC | CAXTON CORP | 2,239,300 2.300% | -1,510,590 (-40.28%) | Filing |
| 2021-02-16 4:23 pm Sale | 2020-12-31 | 13G | CTI BioPharma Corp. CTIC | CAXTON CORP | 3,749,890 5.100% | -737,427 (-16.43%) | Filing |
| 2020-10-01 5:55 pm Purchase | 2020-02-13 | 13G | CTI BioPharma Corp. CTIC | CAXTON CORP | 4,487,317 6.100% | 4,487,317 (New Position) | Filing |